Cargando…

O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer

Dysregulation of tumor suppressor protein E-cadherin is an early molecular event in cancer. O-mannosylation profile of E-cadherin is a newly-described post-translational modification crucial for its adhesive functions in homeostasis. However, the role of O-mannosyl glycans in E-cadherin-mediated cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Sandra, Oliveira, Tiago, Bartels, Markus F., Miyoshi, Eiji, Pierce, Michael, Taniguchi, Naoyuki, Carneiro, Fátima, Seruca, Raquel, Reis, Celso A., Strahl, Sabine, Pinho, Salomé S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323151/
https://www.ncbi.nlm.nih.gov/pubmed/27533452
http://dx.doi.org/10.18632/oncotarget.11245
_version_ 1782509977517162496
author Carvalho, Sandra
Oliveira, Tiago
Bartels, Markus F.
Miyoshi, Eiji
Pierce, Michael
Taniguchi, Naoyuki
Carneiro, Fátima
Seruca, Raquel
Reis, Celso A.
Strahl, Sabine
Pinho, Salomé S.
author_facet Carvalho, Sandra
Oliveira, Tiago
Bartels, Markus F.
Miyoshi, Eiji
Pierce, Michael
Taniguchi, Naoyuki
Carneiro, Fátima
Seruca, Raquel
Reis, Celso A.
Strahl, Sabine
Pinho, Salomé S.
author_sort Carvalho, Sandra
collection PubMed
description Dysregulation of tumor suppressor protein E-cadherin is an early molecular event in cancer. O-mannosylation profile of E-cadherin is a newly-described post-translational modification crucial for its adhesive functions in homeostasis. However, the role of O-mannosyl glycans in E-cadherin-mediated cell adhesion in cancer and their interplay with N-glycans remains largely unknown. We herein demonstrated that human gastric carcinomas exhibiting a non-functional E-cadherin display a reduced expression of O-mannosyl glycans concomitantly with increased modification with branched complex N-glycans. Accordingly, overexpression of MGAT5-mediated branched N-glycans both in gastric cancer cells and transgenic mice models led to a significant decrease of O-mannosyl glycans attached to E-cadherin that was associated with impairment of its tumour suppressive functions. Importantly, overexpression of protein O-mannosyltransferase 2 (POMT2) induced a reduced expression of branched N-glycans which led to a protective effect of E-cadherin biological functions. Overall, our results reveal a newly identified mechanism of (dys)regulation of E-cadherin that occur through the interplay between O-mannosylation and N-glycosylation pathway.
format Online
Article
Text
id pubmed-5323151
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53231512017-03-23 O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer Carvalho, Sandra Oliveira, Tiago Bartels, Markus F. Miyoshi, Eiji Pierce, Michael Taniguchi, Naoyuki Carneiro, Fátima Seruca, Raquel Reis, Celso A. Strahl, Sabine Pinho, Salomé S. Oncotarget Research Paper Dysregulation of tumor suppressor protein E-cadherin is an early molecular event in cancer. O-mannosylation profile of E-cadherin is a newly-described post-translational modification crucial for its adhesive functions in homeostasis. However, the role of O-mannosyl glycans in E-cadherin-mediated cell adhesion in cancer and their interplay with N-glycans remains largely unknown. We herein demonstrated that human gastric carcinomas exhibiting a non-functional E-cadherin display a reduced expression of O-mannosyl glycans concomitantly with increased modification with branched complex N-glycans. Accordingly, overexpression of MGAT5-mediated branched N-glycans both in gastric cancer cells and transgenic mice models led to a significant decrease of O-mannosyl glycans attached to E-cadherin that was associated with impairment of its tumour suppressive functions. Importantly, overexpression of protein O-mannosyltransferase 2 (POMT2) induced a reduced expression of branched N-glycans which led to a protective effect of E-cadherin biological functions. Overall, our results reveal a newly identified mechanism of (dys)regulation of E-cadherin that occur through the interplay between O-mannosylation and N-glycosylation pathway. Impact Journals LLC 2016-08-12 /pmc/articles/PMC5323151/ /pubmed/27533452 http://dx.doi.org/10.18632/oncotarget.11245 Text en Copyright: © 2016 Carvalho et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Carvalho, Sandra
Oliveira, Tiago
Bartels, Markus F.
Miyoshi, Eiji
Pierce, Michael
Taniguchi, Naoyuki
Carneiro, Fátima
Seruca, Raquel
Reis, Celso A.
Strahl, Sabine
Pinho, Salomé S.
O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title_full O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title_fullStr O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title_full_unstemmed O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title_short O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer
title_sort o-mannosylation and n-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of e-cadherin in cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323151/
https://www.ncbi.nlm.nih.gov/pubmed/27533452
http://dx.doi.org/10.18632/oncotarget.11245
work_keys_str_mv AT carvalhosandra omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT oliveiratiago omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT bartelsmarkusf omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT miyoshieiji omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT piercemichael omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT taniguchinaoyuki omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT carneirofatima omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT serucaraquel omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT reiscelsoa omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT strahlsabine omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer
AT pinhosalomes omannosylationandnglycosylationtwocoordinatedmechanismsregulatingthetumoursuppressorfunctionsofecadherinincancer